1. How to submit my research paper? What’s the process of publication of my paper?
The journal receives submitted manuscripts via email only. Please submit your research paper in .doc or.pdf format to the submission email: ijpmbs@ejournal.net.
You’ll be given a paper number if your submission is successful. Your paper then will undergo peer review process, which may take approximately one and a half months under normal circumstances, three tops.
After blind peer review, you will receive the notification letter with the review result of your paper...
2. Can I submit an abstract?
The journal publishes full research papers.[Read More]
 
IJPMBS 2026 Vol.15(3): 48-54
doi: 10.18178/ijpmbs.15.3.48-54

Development of 24-hours Long Lasting Sustained-release Bilayered Matrix Tablets of Ondansetron Hydrochloride with the Synergistic Application of ANN and QbD

Pavel Rahman Tonmoy * and Nahid Sharmin
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh
Email: pavelrahman-2015618070@pharmacy.du.ac.bd (P.R.T.)
*Corresponding author

Manuscript received June 22, 2026; accepted July 3, 2026; published July 30, 2026.

Abstract—To address the limitations of short-acting ondansetron, this study developed a 24-hour bilayer (tab-in-tab) sustained-release tablet using Quality by Design (QbD) and Artificial Neural Networks (ANNs). The optimized Formulation (F4) combined an 8 mg sustained-release core with a 4 mg immediate-release layer. Results showed 96.88% of drug release over 24 h, following zero-order kinetics via diffusion and erosion. This computational framework significantly reduced trial-and-error costs while ensuring consistent therapeutic plasma levels, potentially improving patient adherence in chemotherapy-induced emesis.
 
Keywords—ondansetron hydrochloride, bilayered matrix tablet, Quality by Design (QbD), Artificial Neural Networks (ANN), zero-order kinetics

Cite: Pavel Rahman Tonmoy and Nahid Sharmin, "Development of 24-hours Long Lasting Sustained-release Bilayered Matrix Tablets of Ondansetron Hydrochloride with the Synergistic Application of ANN and QbD," International Journal of Pharma Medicine and Biological Sciences, Vol. 15, No. 3, pp. 48-54, 2026.

Copyright © 2026 by the authors. This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Copyright © 2012-2026. International Journal of Pharma Medicine and Biological Sciences. Unless otherwise stated.
​E-mail: ijpmbs@ejournal.net
Published by